zimmytws SPAC Newcourt Acquisition Corp. (NASDAQ:NCAC) shareholders have voted to approve a planned merger with psilocybin therapy developer Psyence Biomed (OTCQB:PSYGF), but the deal may not be able to close…
Mikko Lemola NeOnc Technologies (NTHI) has upsized its proposed IPO to $75M from $50M. The brain cancer therapy developer indicated in an SEC filing that it was now looking to…
phive2015 Canaccord Genuity said Tuesday that it regards the sell-off in Corcept Therapeutics (NASDAQ:CORT) shares as a buying opportunity, given that the company intends to appeal a recent court decision…
sutthirat sutthisumdang Baird has chosen Alcon (NYSE:ALC), Stryker (NYSE:SYK), The Cooper Companies (NASDAQ:COO), Axonics (NASDAQ:AXNX) and Boston Scientific (NYSE:BSX) as its top medtech picks for 2024. While allowing that medtech…
Hailshadow PTC Therapeutics (NASDAQ:PTCT) said it has submitted a briefing document to support renewal of its conditional approval for Translarna in Europe and plans to meet with the FDA in…